These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 21172673)

  • 1. Management of multidrug-resistant tuberculosis in children: a survival guide for paediatricians.
    Schaaf HS; Marais BJ
    Paediatr Respir Rev; 2011 Mar; 12(1):31-8. PubMed ID: 21172673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent advances in the diagnosis and treatment of multidrug-resistant tuberculosis.
    Ahmad S; Mokaddas E
    Respir Med; 2009 Dec; 103(12):1777-90. PubMed ID: 19660927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of drug-resistant tuberculosis.
    Chiang CY; Schaaf HS
    Int J Tuberc Lung Dis; 2010 Jun; 14(6):672-82. PubMed ID: 20487603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Failure of chemoprophylaxis with standard antituberculosis agents in child contacts of multidrug-resistant tuberculosis cases.
    Sneag DB; Schaaf HS; Cotton MF; Zar HJ
    Pediatr Infect Dis J; 2007 Dec; 26(12):1142-6. PubMed ID: 18043453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mini epidemic of isoniazide resistant TB in rural TN: a need for supervised preventive therapy.
    Mehta J; Keith R; Al Hasan M; Ryland B; Roy T
    Tenn Med; 2009 Aug; 102(8):41-4. PubMed ID: 19691201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors and outcome of human immunodeficiency virus-infected patients with sporadic multidrug-resistant tuberculosis in New York City.
    Mannheimer SB; Sepkowitz KA; Stoeckle M; Friedman CR; Hafner A; Riley LW
    Int J Tuberc Lung Dis; 1997 Aug; 1(4):319-25. PubMed ID: 9432387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two pediatric cases of multidrug-resistant tuberculosis treated with linezolid and moxifloxacin.
    Pinon M; Scolfaro C; Bignamini E; Cordola G; Esposito I; Milano R; Mignone F; Bertaina C; Tovo PA
    Pediatrics; 2010 Nov; 126(5):e1253-6. PubMed ID: 20974784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of multidrug-resistant tuberculosis: Update 2007.
    Yew WW; Leung CC
    Respirology; 2008 Jan; 13(1):21-46. PubMed ID: 18197909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multidrug-resistant tuberculous meningitis in children in Durban, South Africa.
    Padayatchi N; Bamber S; Dawood H; Bobat R
    Pediatr Infect Dis J; 2006 Feb; 25(2):147-50. PubMed ID: 16462292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Controlling multidrug-resistant tuberculosis and access to expensive drugs: a rational framework.
    Pablos-Mendez A; Gowda DK; Frieden TR
    Bull World Health Organ; 2002; 80(6):489-95; discussion 495-500. PubMed ID: 12132008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chapter 4: childhood contact screening and management.
    World Health Organization Stop TB Partnership Childhood TB Subgroup
    Int J Tuberc Lung Dis; 2007 Jan; 11(1):12-5. PubMed ID: 17217124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV infection and multidrug-resistant tuberculosis: the perfect storm.
    Wells CD; Cegielski JP; Nelson LJ; Laserson KF; Holtz TH; Finlay A; Castro KG; Weyer K
    J Infect Dis; 2007 Aug; 196 Suppl 1():S86-107. PubMed ID: 17624830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of multi-drug resistant tuberculosis: practitioner's view point.
    Prasad R
    Indian J Tuberc; 2007 Jan; 54(1):3-11. PubMed ID: 17455417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Recommendations of the Spanish Society for Pediatric Infectious Diseases (SEIP) on the management of drug-resistant tuberculosis].
    Mellado Peña MJ; Baquero-Artigao F; Moreno-Perez D;
    An Pediatr (Barc); 2009 Nov; 71(5):447-58. PubMed ID: 19819205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contact investigations as a means of detection and timely treatment of persons with infectious multidrug-resistant tuberculosis.
    Bayona J; Chavez-Pachas AM; Palacios E; Llaro K; Sapag R; Becerra MC
    Int J Tuberc Lung Dis; 2003 Dec; 7(12 Suppl 3):S501-9. PubMed ID: 14677844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methodological issues in the design of clinical trials for the treatment of multidrug-resistant tuberculosis: challenges and opportunities.
    Lienhardt C; Davies G
    Int J Tuberc Lung Dis; 2010 May; 14(5):528-37. PubMed ID: 20392344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Multidrug resistant tuberculosis in Iceland--case series and review of the literature].
    Asgeirsson H; Blöndal K; Blöndal T; Gottfredsson M
    Laeknabladid; 2009; 95(7-8):499-507. PubMed ID: 19553708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug-resistant tuberculosis in Ethiopia: problem scenarios and recommendation.
    Abate G
    Ethiop Med J; 2002 Jan; 40(1):79-86. PubMed ID: 12240570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multidrug-resistant tuberculosis: epidemiology, risk factors and case finding.
    Caminero JA
    Int J Tuberc Lung Dis; 2010 Apr; 14(4):382-90. PubMed ID: 20202293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.